D. von Delft

Digital health for the End TB Strategy: developing priority products and making them work

R. Garfein, D. Falzon, I. Abubakar, 2016, European Respiratory Journal.

The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?

S. Koenig, H. Cox, A. von Delft, 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis.

E. Nardell, Alimuddin Zumla, R. Duarte, 2017, Presse medicale.

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions

M. Pai, K. Dheda, J. Peter, 2022, The Lancet Respiratory Medicine.

Post-tuberculosis lung health: perspectives from the First International Symposium.

S. Datta, R. Wallis, A. Rachow, 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Exposed, but Not Protected: More Is Needed to Prevent Drug-Resistant Tuberculosis in Healthcare Workers and Students.

Alimuddin Zumla, A. von Delft, D. von Delft, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives.

H. Cox, D. von Delft, C. Mitnick, 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Why healthcare workers are sick of TB.

Alimuddin Zumla, T. Nyirenda, M. Maeurer, 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

The evolving role of advocacy in tuberculosis.

D. von Delft, D. Wegener, A. DeLuca, 2014, The Lancet. Respiratory medicine.